Kreon Finnancial (530139)
Score breakdown: P/E: 3/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹39.13 |
| Market Cap | ₹80.34 Cr |
| P/E Ratio | 10.86 |
| ROCE | -2.17% |
| ROE | 16.73% |
| Dividend Yield | 0% |
| Profit Growth | 128.76% |
| Debt/Equity | — |
| Sales Growth | 54.11% |
| 52-Week Range | ₹23.92 — ₹42.73 |
| Sector | Finance |
| Book Value | ₹17.99 |
AI Analysis
AI-generated, general educational analysis — not personal investment advice.
At ₹39.13, Kreon Finnancial presents an intriguing but incomplete picture. A P/E of 10.86 and a PEG of 0.12 suggest the market is pricing in very little of the recent 128.76% profit growth and 54.11% sales growth. As Graham would say, numbers are the starting point, not the whole story. The ROE of 16.73% is respectable, and book value of ₹17.99 gives some support—though at P/B 2.18, you're paying a premium for that book. What worries me is ROCE at -2.17% for an NBFC; this suggests the core operating returns are not healthy, or there are measurement oddities. With no debt/equity data and no promoter holding disclosed, I cannot assess leverage or insider alignment. The latest quarter sales of ₹10 Cr and net profit of ₹1 Cr show a margin of 10%, but annualized that profit is far below what the P/E implies—so I must rely on the reported trailing P/E. This is a fast grower, but a fragile one. There is no dividend, so return must come solely from price appreciation. A F-Score of 6 out of 9 is passable, but not a clean bill of health. As Buffett, I prefer businesses with predictable cash flows and durable moats. Kreon is small, speculative, and data-deficient. I'd keep it on the watchlist, but only a very small position, if any, until leverage, promoter holding, and the profitability trajectory become clearer.
The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer